Abstract: A digital health solution system includes: a virtual pharmacy including one or more processors configured to operate a web portal for user devices via a network, the web portal serving as a marketplace for digital health solution applications available for download by and activation on user devices; a digital health marketplace including one or more processors configured to, in response to receipt of user input from a user device: determine activation criteria for a selected one of the digital health solution applications; and transmit the activation criteria to the virtual pharmacy, where the one or more processors of the virtual pharmacy are configured to transmit the activation criteria to the user device via the network; and where the user device is configured to, using the activation criteria, at least one of download and activate the selected one of the digital health solution applications.

Abstract: Food processing devices capable of performing multiple functions, including mixing and extruding pasta or other food products, are described. The food processing devices have a base, a mixing bowl mountable on the base, a mixing assembly, and an extruder. The base has a first motor operably coupled to drive the mixing assembly when the mixing bowl is coupled to the base, a data store arranged to store a plurality of computer-readable signals defining at least a first sequence of food processing instructions, and a controller in electronic communication with the data store. The controller is operable to execute the plurality of computer-readable signals, the execution of which controls the first motor to actuate the mixing assembly for at least a first period of time to produce mixed food items and controls operation of the extruder for at least a second period of time, causing extrusion of the mixed food items.

Abstract: A beverage production system is provided that includes a turntable assembly comprising a central axis. The turntable assembly further includes an inner turntable and an outer turntable disposed circumferentially about the inner turntable. The beverage production system also includes a cup dispensing station configured to dispense cups onto one of the inner or outer turntables. The beverage production system also includes a beverage dispensing station configured to dispense a beverage into the cups.

Abstract: A device includes a flexible Peltier; a power supply in electrical communication with the flexible Peltier; a control switch electrically coupled to the power supply and the flexible Peltier. The control switch is configured to control direction of current supplied from the power supply to the flexible Peltier, and at least one flexible layer is coupled to the flexible Peltier. The at least one flexible layer is configured to retain the flexible Peltier about a portion of a subject.

Abstract: Approaches are provided for a prediction model determining a prediction indicative of the authorized user being associated with at least one anomaly event. In one example, a computer system may receive data from different sources. For example, the system may receive data associated with use of one or more monitored units of an automated storage and retrieval location. The system may also receive request data associated with a request for execution of the monitored controlled unit by an authorized user to a target user. The prediction model of the system may utilize the received data to determine the prediction that the authorized user is associated with at least one anomaly event associated with a diversion of a monitored unit away from the target user. The system may then provide the prediction for presentation.

Abstract: Disclosed herein are methods, systems, and processes for accepting and servicing interface agnostic validated unified platform queries. A request for shared data associated with web applications received from a user interface that is rendered by a client based on a specification is intercepted. The request is forwarded to a unified application programming interface (API) instead of a disparate unique API associated with the web applications. The request from the client is authenticated externally using the unified API and the request for the shared data is authorized to be displayed in the user interface based on the unified API instead of the specification.

Abstract: Techniques relating to monitoring map consistency are described. In an example, a monitoring component associated with a vehicle can receive sensor data associated with an environment in which the vehicle is positioned. The monitoring component can generate, based at least in part on the sensor data, an estimated map of the environment, wherein the estimated map is encoded with policy information for driving within the environment. The monitoring component can then compare first information associated with a stored map of the environment with second information associated with the estimated map to determine whether the estimated map and the stored map are consistent. Component(s) associated with the vehicle can then control the object based at least in part on results of the comparing.

Abstract: The present invention relates to a process for reducing malodors on fabrics using an acid delivery composition.

Abstract: A work machine includes a frame, a traction system, an engine, an implement system, an operator cab with a roof; a machine control system, and a secondary control system. The secondary control system is configured to interface with the machine control system and includes a secondary control device, a control module, a communication module, a base plate, and two rails. The base plate is configured to support the control module and the communication module, and protect the plurality of harness connections. The two rails are configured to support the base plate in an operation orientation and a service orientation and each include a plurality of channels configured to support the base plate in the service orientation.

Abstract: A beverage production system is provided that includes a cup dispensing station configured to dispense cups and a beverage dispensing station configured to dispense a beverage. The beverage production system also includes a turntable assembly having a central axis, an inner turntable including a row of cup receptacles, and an outer turntable disposed circumferentially about the inner turntable. The inner turntable configured to rotate about the central axis to align the cup receptacles of the row with the cup dispensing station and the beverage dispensing station. The turntable assembly configured to align an opening in the turntable assembly with a cup receptacle in the row, the opening adjacent the outer turntable. The beverage production system also having an actuator configured to move a cup positioned in the cup receptacle in the row onto the outer turntable.

Abstract: Embodiments provide an NDEF interface on a co-badged user card (e.g., a payment card storing multiple payment applications or accounts) to modify the payment application selection status on the co-badged card using a mobile application provided on a user device with NDEF support. The NDEF interface on the co-badged card allows communication with the mobile application stored on the user device operating a variety of operating systems (e.g., iOS and Android).

Abstract: A method includes capturing, via a microphone, noise data associated with the user sleeping. The method also includes detecting, based on the noise data, a trigger event. The method also includes, in response to detecting the trigger event, storing at least a portion of the noise data. The method also includes calculating, by a control system based on the at least a portion of the noise data, the sleep score for the user.

Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: Microdevices and methods provide for separating cells of a single type from a mixed biological sample containing multiple types of cells. A single microdevice may be configured to allow for separating out cells into multiple groupings, each grouping containing cells of only one cell type. Transfer of separated cells off the microdevice is performed by physical separation of part of the microdevice from a remainder of the microdevice. This step advantageously minimizes accidental cell losses in the transfer. Subsequent analysis may then be performed using non-microfluidic equipment and techniques.

Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which m, Y1, Y2, Y3, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a and R5b are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which m, Y1, Y2, Y3, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a and R5b are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which Y1, Y2, Y3, Y4 R1, R2, R4a, R4b, R5a, R5b, R6a and R6b are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.

Abstract: The present invention relates to compounds of formula I: in which p, q, Y1, Y2, R1, R2a, R2b, R3a, R3b, R4a, R4b, R5a, R5b, R7 and R8 are defined in the Summary of the Invention; capable of inhibiting the activity of SHP2. The invention further provides a process for the preparation of compounds of the invention, pharmaceutical preparations comprising such compounds and methods of using such compounds and compositions in the management of diseases or disorders associated with the aberrant activity of SHP2.